Close to 500 players claim to have the required capabilities to provide a wide array of services for pharmaceutical drug
Close to 500 players claim to have the required capabilities to provide a wide array of services for pharmaceutical drug
LONDON, ENGLAND, UNITED KINGDOM, October 14, 2021 /EINPresswire.com/ -- The incremental evolution in product discovery, clinical investigation and manufacturing methods have rendered outsourcing a crucial aspect of pharmaceutical development and production. Considering the various advantages associated with outsourcing certain operations, we are led to believe that the pharmaceutical contract manufacturing market is likely to witness positive growth in the coming years.
Roots Analysis3 has announced the addition of “Pharmaceutical Contract Manufacturing Market2 (3rd Edition), 2021-2030” report to its list of offerings.
To order this 510 page report, which features 180+ figures and 175+ tables, please visit
https://www.rootsanalysis.com/reports/view_document/pharmaceutical-contract-manufacturing-market/191.html
The financial opportunity within the pharmaceutical contract manufacturing market has been analyzed across the following segments:
Type of Business Segment
API
FDF
Type of API Manufactured
Generics
Originator
Type of FDF Offered
Oral Solids
Parenteral
Others
Scale of Operation
Clinical
Commercial
Type of Packaging Form Offered
Bottles
Blisters
Injectables
Others
Type of End-User
Small
Mid-sized
Large
Region
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
The Pharmaceutical Contract Manufacturing Market (3rd Edition), 2021-2030 report features detailed profiles of key service providers in this domain:
AMRI Global
Altasciences
Cambrex
Catalent
DPT Laboratories
Thermo Fisher Scientific
Aenova Group
Almac Group
Corden Pharma
Fresenius Kabi
Glatt
Hovione
Recipharm
Siegfried
CMIC Group
Nectar Lifesciences
Syngene
WuXi AppTec
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Regulatory Landscape for Pharmaceutical Contract Manufacturers
5. Pharmaceutical CMOs: current market landscape
6. Regional capability
7. Company profiles
8. Make versus Buy Decision Framework
9. Mergers and Acquisitions
10. Recent Expansions
11. Capacity Analysis
12. Demand Analysis
13. Market Forecast
14. Key Insights
15. SWOT Analysis
16. Case Study: Comparison of Small and Large Molecules Drugs / Therapies
17. Concluding Remarks
18. Executive insights
19. Appendix I: Tabulated Data
20. Appendix II: List of Companies and Organizations
For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/pharmaceutical-contract-manufacturing-market/191.html or email sales@rootsanalysis.com
To purchase a copy, please visit Pharmaceutical Contract Manufacturing Market (3rd Edition), 2021-2030
Contact Details
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnson@rootsanalysis.com
Gaurav Chaudhary
Roots Analysis
+1 415-800-3415
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
1 https://www.rootsanalysis.com/reports/view_document/pharmaceutical-contract-manufacturing-market/191.html
2 https://www.rootsanalysis.com/reports/view_document/pharmaceutical-contract-manufacturing-market/191.html
3 https://www.rootsanalysis.com